The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 3
  • 1
    Merali, Hasnain Mohammed Taki, Mr.
    Director born in December 1964
    Individual (12 offsprings)
    Officer
    2022-08-05 ~ now
    OF - Director → CIF 0
  • 2
    Dewji, Mohamedraza Mohsin
    Director born in July 1986
    Individual (4 offsprings)
    Officer
    2022-08-05 ~ now
    OF - Director → CIF 0
  • 3
    Suite D5, Meryl Suite, Carpenders Park, Watford, Hertfordshire, United Kingdom
    Active Corporate (3 parents, 1 offspring)
    Equity (Company account)
    2,155 GBP2024-03-31
    Person with significant control
    2022-08-05 ~ now
    PE - Ownership of shares – 75% or more → CIF 0
    PE - Right to appoint or remove directors → CIF 0
Ceased 3
  • 1
    Khaki, Kamruddin Fidahusein
    Director born in October 1950
    Individual (2 offsprings)
    Officer
    2017-12-13 ~ 2022-08-05
    OF - Director → CIF 0
  • 2
    Jaffer, Lyakat Gulamhusein
    Director born in May 1951
    Individual (2 offsprings)
    Officer
    2017-12-13 ~ 2018-02-19
    OF - Director → CIF 0
  • 3
    PHARMACO JIBA LIMITED - 1999-11-24
    Unit 4, Boultbee Business Units, Nechells Place, Birmingham, United Kingdom
    Active Corporate (3 parents, 2 offsprings)
    Profit/Loss (Company account)
    542,458 GBP2023-04-01 ~ 2024-03-31
    Person with significant control
    2017-12-13 ~ 2022-08-05
    PE - Ownership of shares – 75% or more → CIF 0
    PE - Ownership of voting rights - 75% or more → CIF 0
    PE - Right to appoint or remove directors → CIF 0
parent relation
Company in focus

PHARMACO WEMBLEY LIMITED

Standard Industrial Classification
47730 - Dispensing Chemist In Specialised Stores
Brief company account
Intangible Assets
113,798 GBP2024-03-31
142,246 GBP2023-03-31
Property, Plant & Equipment
34,129 GBP2024-03-31
40,152 GBP2023-03-31
Fixed Assets
147,927 GBP2024-03-31
182,398 GBP2023-03-31
Debtors
87,108 GBP2024-03-31
90,469 GBP2023-03-31
Cash at bank and in hand
150,309 GBP2024-03-31
95,703 GBP2023-03-31
Current Assets
266,799 GBP2024-03-31
211,444 GBP2023-03-31
Creditors
Current, Amounts falling due within one year
-300,797 GBP2024-03-31
-308,738 GBP2023-03-31
Net Current Assets/Liabilities
-33,998 GBP2024-03-31
-97,294 GBP2023-03-31
Total Assets Less Current Liabilities
113,929 GBP2024-03-31
85,104 GBP2023-03-31
Net Assets/Liabilities
106,300 GBP2024-03-31
77,475 GBP2023-03-31
Equity
Called up share capital
1 GBP2024-03-31
1 GBP2023-03-31
Retained earnings (accumulated losses)
106,299 GBP2024-03-31
77,474 GBP2023-03-31
Equity
106,300 GBP2024-03-31
77,475 GBP2023-03-31
Average Number of Employees
02023-04-01 ~ 2024-03-31
32022-04-01 ~ 2023-03-31
Intangible Assets - Gross Cost
Net goodwill
284,487 GBP2023-03-31
Intangible Assets - Accumulated Amortisation & Impairment
Net goodwill
170,689 GBP2024-03-31
142,241 GBP2023-03-31
Intangible Assets - Increase From Amortisation Charge for Year
Net goodwill
28,448 GBP2023-04-01 ~ 2024-03-31
Intangible Assets
Net goodwill
113,798 GBP2024-03-31
142,246 GBP2023-03-31
Property, Plant & Equipment - Gross Cost
Other
85,000 GBP2023-03-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Other
50,871 GBP2024-03-31
44,848 GBP2023-03-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Other
6,023 GBP2023-04-01 ~ 2024-03-31
Property, Plant & Equipment
Other
34,129 GBP2024-03-31
40,152 GBP2023-03-31
Trade Debtors/Trade Receivables
Current
66,857 GBP2024-03-31
68,325 GBP2023-03-31
Other Debtors
Amounts falling due within one year
20,251 GBP2024-03-31
22,144 GBP2023-03-31
Debtors
Current, Amounts falling due within one year
87,108 GBP2024-03-31
90,469 GBP2023-03-31
Trade Creditors/Trade Payables
Current
105,370 GBP2024-03-31
94,520 GBP2023-03-31
Amounts owed to group undertakings
Current
174,760 GBP2024-03-31
192,284 GBP2023-03-31
Corporation Tax Payable
Current
17,719 GBP2024-03-31
17,609 GBP2023-03-31
Other Taxation & Social Security Payable
Current
1,388 GBP2024-03-31
1,923 GBP2023-03-31
Other Creditors
Current
1,560 GBP2024-03-31
2,402 GBP2023-03-31
Creditors
Current
300,797 GBP2024-03-31
308,738 GBP2023-03-31
  • PHARMACO WEMBLEY LIMITED
    Info
    Registered number 11109863
    Suite D5, St Meryl Suite, Carpenders Park, Watford, Hertfordshire WD19 5EF
    Private Limited Company incorporated on 2017-12-13 (7 years 7 months). The company status is Active.
    The last date of confirmation statement was made at 2024-12-12
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

qrcode

Privacy notice

Terms and conditions

© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.